🇺🇸 FDA
Patent

US 10683500

UNA oligomers having reduced off-target effects in gene silencing

granted A61KA61K31/713A61K47/14

Quick answer

US patent 10683500 (UNA oligomers having reduced off-target effects in gene silencing) held by ARCTURUS THERAPEUTICS, INC. expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/713, A61K47/14, A61P, A61P25/00